bpc-157 clinical trials latest human oral vs injection The hype around a new class of injectable BPC-157 for athletes and injury
Description
Consult with a healthcare provider experienced in functional medicine and Lyme disease
Background BPC-157 was initially synthesized in the early 1990s and studied for its cytoprotective properties as an anti-ulcer agent
During this period, we may recommend peptide combinations to achieve optimal results
Click below to view useful info on a few of the common conditions we treat: Vitamin B12 Deficiency Correct low nutritional levels
The lyophilized peptide ships within 24h from our -20C cold storage facility in Poland.
